Immune Regulation in Multiple Sclerosis: MicroRNA and Antigen-Presenting Cells

Trial Profile

Immune Regulation in Multiple Sclerosis: MicroRNA and Antigen-Presenting Cells

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Nov 2013

At a glance

  • Drugs Interferon beta-1a (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Apr 2013 Primary endpoint added as reported by ClinicalTrials.gov.
    • 01 Jan 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 04 May 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top